Livongo and Lilly Collaborate on Real-World Diabetes Research
Eli Lilly and Company (NYSE: LLY) and Livongo Health, a leading consumer digital health company focused on empowering all people with chronic conditions to live better and healthier lives, today announced a strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes. Livongo and Lilly aim to publish the results of their collaborative research studies to further advance diabetes care for people worldwide.
#r&d